DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Bridgewater Associates LP

Bridgewater Associates LP lowered its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 40.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 181,352 shares of the medical instruments supplier’s stock after selling 120,669 shares during the quarter. Bridgewater Associates LP owned about 0.09% of DENTSPLY SIRONA worth $4,907,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Scientech Research LLC acquired a new stake in shares of DENTSPLY SIRONA in the 2nd quarter worth approximately $846,000. VELA Investment Management LLC acquired a new stake in DENTSPLY SIRONA in the third quarter worth approximately $2,168,000. M&G Plc bought a new position in DENTSPLY SIRONA during the 2nd quarter valued at $8,817,000. Country Club Bank acquired a new position in shares of DENTSPLY SIRONA during the 3rd quarter valued at $4,084,000. Finally, Empowered Funds LLC bought a new stake in shares of DENTSPLY SIRONA in the 3rd quarter worth $2,468,000. Institutional investors own 95.70% of the company’s stock.

Analysts Set New Price Targets

XRAY has been the subject of several research reports. Leerink Partners cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Barrington Research reduced their price objective on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. Needham & Company LLC dropped their target price on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a report on Friday, October 25th. Robert W. Baird reduced their target price on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a report on Friday, November 8th. Finally, Evercore ISI decreased their price target on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Seven analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $29.50.

DENTSPLY SIRONA Trading Up 0.1 %

DENTSPLY SIRONA stock opened at $19.65 on Friday. The company has a 50 day moving average price of $22.55 and a 200 day moving average price of $24.79. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA Inc. has a 52 week low of $17.21 and a 52 week high of $37.60. The firm has a market capitalization of $3.91 billion, a price-to-earnings ratio of -9.49, a P/E/G ratio of 1.93 and a beta of 1.02.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. The business had revenue of $951.00 million for the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. DENTSPLY SIRONA’s revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.49 earnings per share. Research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.